Our news journalists obtained a quote from the research, "Hepatic metastases of colorectal cancer (HMCRC) are an example of a lesion where treatment with Cyberknife ® r is indicated because they are located in a radiosensitive organ and curative treatment is based on focal eradication (resection, radiofrequency ablation,...). The local control rate at one year is reported to be 70 to 100% depending on the study. Tolerance is excellent with less than a 5% rate of acute grade 3 or 4 side effects (nausea, vomiting, gastro-duodenal ulcer). The specific hepatotoxicity of radiotherapy, so-called radiation-induced liver disease (RILD), was found in only one study. Candidates for stereotactic radiotherapy are patients in whom disease is controlled except for intrahepatic disease with 1-3 hepatic metastases = 700 cm(3) and normal liver function. It is actually a very simple treatment that results in very good local control with few contraindications."
According to the news editors, the research concluded: "Its place in the management strategy of liver metastases needs further clarification."
For more information on this research see: Treatment of hepatic metastases of colorectal cancer by robotic stereotactic radiation (Cyberknife ®).
The news correspondents report that additional information may be obtained from D. Peiffert, Inst Cancerol Lorraine, F-54519 Vandoeuvre Les Nancy,
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Shia LaBeouf Plea Deal, Alcoholism Treatment
- Stop-Start Engines Save Gas, Reduce Emissions
- Ohio State Band Chief Fired After Probe
- Hispanic Leader Goes the Extra Mile
- Ukraine Says Russians Firing Across the Border
- Ford Q2 Net Profit up 6 Percent
- Jennifer Lopez, Pitbull to Perform at Fashion Rocks
- Ricky Martin Joins 'The Voice ... Mexico'
- U.S. Weighs Refugee Status for Immigrant Kids
- Morgan Stanley Ponies Up $275 Million to Settle SEC Charges